In Situ Hybridization (ISH) Market Size and Forecasts (2021 - 2031), Global and Regional Share, Trends, and Growth Opportunity Analysis

MARKET OVERVIEW

In Situ Hybridization (ISH) is a process that utilizes labeled DNA or RNA probes to detect complementary DNA or RNA sites in a piece of tissue or in cytological preparation. This technique allows to gain temporary and three-dimensional information about gene expression and genetic site. The in-situ hybridization is similar to the blot hybridization.

MARKET SCOPE

The "Global In Situ Hybridization (ISH) Market Analysis to 2031" is a specialized and in-depth study of the food and beverages industry with a special focus on the global market trend analysis. The report aims to provide an overview of the In Situ Hybridization (ISH) market with detailed market segmentation by technology, application, end user, and geography. The report provides key statistics on the market status of the leading In Situ Hybridization (ISH) market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION

• Based on technology, the global In Situ Hybridization (ISH) market is segmented into Chromogenic In Situ Hybridization and Fluorescence In Situ Hybridization.
• On the basis of application, the market is segmented into Immunology, Microbiology, Cancer Diagnostic, Neuroscience and Infectious Diseases.
• On the basis of End-User, the market is segmented into Biotechnology/Pharmaceutical Companies, Academic & Research Institutes and Molecular Diagnostic Labs.

MARKET DYNAMICS

Drivers

• Increasing Incidence Of Genetic Disorder And Cancer
• Rising Investment In The Field Of Biotechnological And Pharmaceutical R&D Activities

Restraints

• Lack of skilled professionals
• Stringent Regulatory Framework

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2021 to 2031 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America. The In Situ Hybridization (ISH) market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.

The report analyzes factors affecting the market from both demand and supply side and further evaluates market dynamics affecting the marketduring the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the In Situ Hybridization (ISH) market in these regions.

IMPACT OF COVID-19 ON IN SITU HYBRIDIZATION (ISH) MARKET

COVID-19 first began in Wuhan (China) during December 2019 and since then it has spread at a fast pace across the globe. The US, India, Brazil, Russia, France, the UK, Turkey, Italy, and Spain are some of the worst affected countries in terms confirmed cases and reported deaths. The COVID-19 has been affecting economies and industries in various countries due to lockdowns, travel bans, and business shutdowns. Shutdown of various plants and factories has affected the global supply chains and negatively impacted the manufacturing, delivery schedules, and sales of products in global market. However, in situ hybridization (ISH) and immunohistochemistry (IHC) are essential tools to characterize SARS-CoV-2 infection and tropism in naturally and experimentally infected animals and also for diagnostic purposes. Here, we describe three RNAscope®-based ISH assays targeting the ORF1ab, spike, and nucleocapsid genes and IHC assays targeting the spike and nucleocapsid proteins of SARS-CoV-2.The ongoing COVID-19 pandemic has surged the central position of In Situ Hybridization (ISH) in outbreak control.

In Situ Hybridization (ISH) Market Report Analysis

In Situ Hybridization (ISH) Market

• 
  CAGR (2023 - 2031)

  XX%
• Market Size 2023
  US$ XX Million
• Market Size 2031
  US$ XX Million

Report Coverage

• Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope

• Key future trends
• Detailed PEST/Porter’s Five Forces and SWOT analysis

• Industry landscape and competition analysis & recent developments
• Detailed company profiles

• Global and regional market analysis covering key market trends, major players, regulations, and recent market developments

Key Players

• Abbott
• Thermofisher Scientific Inc
• PerkinElmer Inc
• Merck KGaA
• F Hoffmann La Roche Ltd
• Danaher
• BioGenex
• Bio SB
• Exiqon QIAGEN

Regional Overview

• North America
• Europe
• Asia-Pacific
• South and Central America
• Middle East and Africa

Market Segmentation

By Technology

• Chromogenic In Situ Hybridization
• Fluorescence In Situ Hybridization

By Application

• Immunology
• Microbiology
• Cancer Diagnostic
• Neuroscience and Infectious Diseases

By End-User

• Biotechnology/Pharmaceutical Companies
• Academic and Research Institutes and Molecular Diagnostic Labs

Download Free Sample

   Buy Now   

• Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.

MARKET PLAYERS

The report covers key developments in the In Situ Hybridization (ISH) market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the marketwere acquisitions, and partnership & collaborations. These activities have paved way for the expansion of business and customer base of market players. The market payers from In Situ Hybridization (ISH) market are anticipated to lucrative growth opportunities in the future with the rising demand for In Situ Hybridization (ISH) in the global market.

The report also includes the profiles of key companies along with their SWOT analysis and market strategies in the In Situ Hybridization (ISH) market. In addition, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information of the last 3 years, the key development in the past five years.

• Abbott.
• Thermofisher Scientific, Inc.
• PerkinElmer Inc.
• Merck KGaA
• F. Hoffmann-La Roche Ltd
• Danaher
• BioGenex
• Bio SB
• Exiqon (QIAGEN)
• Oxford Gene Technology

The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.

In Situ Hybridization (ISH) Market Report Scope